EPRNEEK |
PLL |
Laminin receptor |
Brain cells |
78 |
SYPGWSW |
mPEG–PLA |
Blood brain barrier |
Brain cells |
79 |
ASSLNIA |
PAMAM |
Skeletal muscle cells |
Skeletal muscle cells |
85 |
Tet1 (HLNILSTLWKYRC) |
PEI, other polycations |
Peripheral neurons |
Brain cells |
133 |
YQQVLTSLPSQNVLQI-ANDLENLRDLLHLL |
PLL |
Leptin receptor |
Brain cells |
134 |
CGHKAKGPRK |
PEG–PLA |
Transferrin receptor |
Brain, cancer cells |
136 |
RGDPAYQGRFL |
PEO-b-PCL |
Breast cancer cells |
Breast cancer cells |
l45 |
WXEAAYQRFL |
PEO-b-PCL |
Breast cancer cells |
Breast cancer cells |
l45 |
PGFAPLTSRGSQQYAA |
P(LA-co-TMCC)-g-PEG |
Taxane chemotherapeutic agents |
Drug loading |
147 |
YHWYGYTPQNVIGGGGC |
PAMAM–PLA–OH |
EGFR receptor |
Triple negative breast cancer |
148 |
IFLLWQR |
Aldehyde–PEG-PLA and mPEG–PLA |
Annexin 1 |
Breast cancer |
149 |
YLFFVFER |
PEG–PAMAM |
HER2 |
Breast cancer cells |
150 |
KTLLPTP |
PEGylated PEI |
Plectin-1 |
Pancreatic cancer cells |
153 |
d-Tyr-Arg-Arg-2-Nal-Gly |
Chitosan |
CXCR4 |
Lung cancer, CXCR4 overexpressing cancer cells |
155 |
RLWMRWYSPRTRAYGC |
PEG-P(TMC-DTC)-PEI |
Tumor cells |
Lung, colon, breast, liver, leukemia cancers |
156 |
YTIWMPENPRPGTPCDI-FTNSRGKRASNG |
PAM-ABP |
Nicotinic acetylcholine receptor |
Stem cell |
157 |
SGHQLLLNKMPNGGGSC |
PAMAM |
Mesenchymal stem cells |
Stem cell |
158 |
aKXVAAWTLKAAaZC |
PAMAM |
Major histocompatibility complex class II |
Antigen presenting cells |
160 |
HAIYPRH |
PEI |
Transferrin receptor |
Breast, colon, liver, and lung cancer cells |
168 |
CAGW |
PLGA-g-PEI |
Endothelial cells |
Cardiovascular cells |
177 |
REDV |
Chitosan |
Endothelial cells |
Cardiovascular cells |
178 |
WLSEAGPVVTVRALR-GTGSW |
CBA-DAH |
Primary cardiomyocytes |
Cardiovascular cells |
180 |
SDSSD |
Polyurethane |
Osteoblasts |
Bone cells |
183 |
QHREDGS |
Chitosan, collagen |
Angiopoietin-1 |
Cardiomyocytes |
192 |
LTVSPWY |
Chitosan |
HER2 |
Breast cancer cells |
196 |